Mineralys Therapeutics, Inc. MLYS Number of Exercisable Options
Number of Exercisable Options at other companies
Other financials
Where this comes from
Reported directly by Mineralys Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber.
The official record: Mineralys Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Mineralys Therapeutics, Inc.'s number of exercisable options.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Mineralys Therapeutics, Inc.'s number of exercisable options?
- Mineralys Therapeutics, Inc. (MLYS) reported number of exercisable options of 2M in Q4 2025.
- What is the long-term trend for Mineralys Therapeutics, Inc.'s number of exercisable options?
- Over 2 years (2023 to 2025), Mineralys Therapeutics, Inc.'s number of exercisable options has grown at a 105.3% compound annual growth rate (CAGR), from 464.9K to 2M.
- What does number of exercisable options mean?
- The number of share-based payment options that have met all vesting requirements and are currently eligible for exercise by the holders. This represents the portion of the equity incentive pool that could be converted into common stock immediately. It is a critical component for calculating fully diluted share counts.